Summan-Because genetic predisposition probably plays an important role in the aetiology of most of childhood cancers. studies of second primaries occurring after these cancers may be particularly informative about possible common genetic mechanisms in both of these cancers. We have studied the incidence of thyroid tumours occumng after cancer in childhood in a cohort of 592 children treated before 1970. Among these children. six later developed a thyroid carcinoma, and 18 developed a thyroid adenoma. Radiation doses received to the thyToid by each of the irradiated children have been estimated using individual radiotherapeutic technical records. Thyroid carcinomas and thyroid adenomas were five times more frequent after irradiation for neuroblastoma than after irradiation for anv other first cancer. This ratio did not depend on sex. nor on time elapsed since irradiation. nor on dose of radiation received for the thyToid gland. This result suggests that there is a common mechanism for the occurrence of neuroblastoma and of differentiated thyroid tumour.
Epidemiological studies of second primary cancers may be of great help in improving the knowledge of carcinogenesis. because evidence for association between two types of cancer may lead to the formulation of hypotheses concerning common mechanisms in both of these cancers. The observation of an excess incidence of osteosarcoma after bilateral retinoblastoma has led to the suggestion that the anti-oncogene Rb. which controls for retinoblastoma. played a role in the development of osteosarcoma. and this role has been demonstrated later (Knudson. 1971 : Hansen et al.. 1985 .
If such an association between two cancers is less strong. a cohort study including several types of first cancers needs to be organised in order to identify this association and to be able to adjust for the carcinogenic effects of the first cancer treatment.
We report here the results of a cohort study monitored in order to analyse the risk of thyroid tumour after a first cancer in childhood.
Methods

Patients
This study included all the 592 children treated for a cancer at the Gustave-Roussy Institute (IGR) between 1942 and 1969 and who were alive and free of disease 5 years after diagnosis, excluding 22 children treated for a thyroid cancer and 20 who had received brachytherapy. Those latter 20 children were excluded in order to include only patients treated with the same type of radiation at a similar dose rate. The diagnosis of cancer was confirmed by histology, cytology and measurements of tumour marker levels, or clinically when a tumour sample was not available, notably for brain tumours. The absence of children treated for leukaemia (Table I) is due to the fact that IGR is an important reference centre in France for solid paediatric cancers. All children were followed-up by one of us (O.S.). Only clinically apparent tumours of the thyroid gland were recorded.
Dosimetry
The dose and duration of each drug received by the 592 children. and information on radiotherapy were extracted from medical records (Table I) . Of the 592 children. 496 received X or gamma radiation. For each of these patients. the radiation doses to the two lobes of the thyroid gland were estimated retrospectively using individual radiotherapeutic technical records. The estimation involved two steps. The first step estimated the position of the two lobes of the thyroid gland from the size of the child at time of treatment, using a child phantom model based on auxometrical curves (Francois et al.. 1989a) . The second step used a model which describes the variation of the dose in and outside the treatment beam. taking into account the quality of the radiation. the characteristics of the treatment machine (collimator and machine head construction) and the field shape (Francois et al.. 1989b) . For each of the children in the studv. data for this second step were obtained from the technical reports and from the controls films.
Statistical methods
The cumulative incidence of thyroid tumour was estimated using the Kaplan-Meier method (Kaplan & Meier. 1958) .
The analysis of risk for given categories was performed using the Cox's regression model (Cox. 1972 Figure 2 presents the relative risks in Table II . and those predicted from a linear relationship using the same coefficient for neuroblastoma and other tumours.
As previously reported (de Vathaire et al.. 1988 (de Vathaire et al.. . 1989a . excluding thyroid tumours, no more second tumours were found after irradiation for a neuroblastoma (three of 75) than for other type of first cancer (24 of 421) (RR = 0.80).
Contrary to other authors (Cohen et al.. 1990 ). we did not find any parathyroid adenoma associated with the thyroid tumours.
Dscussio
Our results were not affected by the important proportion of subjects lost to follow-up (22%): under the extreme assumption, more probable in France, that all children lost to follow-up were alive and free of thyroid tumour at the end of 1985. the relative risk of thyroid tumour was 4.2 (95% CI: 1.9-9.5) for neuroblastomas, compared with that for other tumours.
Tucker et al. (1991) suggested an excess of thyroid cancers after dactinomycin. We not confirm this result.
The two other studies of second thyroid tumours after cancer treatment considered only thyroid carcinomas and not adenomas. The Late Effect Study Group (Tucker et al.. 1984 (Tucker et al.. : 1991 , a hospital-based study. observed seven second thyroid cancers among the 790 patients irradiated for neuroblastoma. compared with 16 among the 8.380 others. When the dose received to the thyroid was not taken into account, the risk of thyroid cancer was found to be 7.7 times higher after (Hawkins et al., 1987) involving more than 10,000 3-year survivors of childhood cancer, only three thyroid cancers were observed. No thyroid cancers were observed after a median follow-up of 13. 5 years among the 134 irradiated neuroblastomas. As a rule, more second cancers, and particularly more thyroid cancers. are found in hospital based-studies than in registry-based studies because of differences in treatment intensity and in extent of diagnostic investigations during follow-up. This difference in frequency is strongly increased for thyroid adenomas. whose diagnosis is difficult, and depends on the importance of nuclear medicine units, that have been particularly developed at IGR. There are biological arguments supporting a relationship between thyroid tumours and neuroblastomas. Firstly, the tumours of the sympathetic system (pheochromocytomas and, in rare instances, neuroblastomas) can be associated with medullary thyroid carcinoma (Sipple, 1961) . Secondly. there is evidence that C cells and epithelial thyroid cells share a common embryological origin (Caillou et al.. 1981) . Thirdly, similar chromosomal deletions or abnormalities have been found in medullary thyroid carcinomas and in epithelial thyroid tumours (Jenkins et al., 1990) .
The higher incidence of thyroid cancer after neuroblastoma suggests a common mechanism for the occurrence of neuroblastoma and of differentiated thyroid tumour. This would imply an increased risk of thyroid tumour among non-irradiated neuroblastoma patients. Our series includes only 24 such children; even with a relative risk of 7.5 (upper level of the 95% CI of our estimation of 5.0) and with a ratio of 10 adenomas for one carcinoma (Van Herle et al., 1982) . The expected number of thyroid tumours among these 24 children. based on incidence rates from the national registry of Denmark (there is no national cancer incidence registry in France). is 0.39 and the probability of observing no thyroid tumour is 67%.
We observe an excess risk of thyroid cancer after neuroblastoma which could be compared with the excess of osteosarcoma after bilateral retinoblastoma. Nevertheless, the mechanism of the association between thyroid tumour and neuroblastoma is probably different for two reasons. (Figure 2 ). This is an argument against the hypothesis that the effects of radiation on the two alleles of an anti-oncogene controlling for a radio-induced cancer (bone cancer after retinoblastoma or thyroid tumour after neuroblastoma) are independent. Such independence. and the linear dose-response relationship observed for patients with germinal mutation. would imply a quadratic relationship for the other patients. contrary to what is observed.
Attention should be paid to the fact that both our results. and those found for osteosarcomas are bilateral retinoblastomas, only concern situations in which the total dose is delivered by fractions of several minutes each. Repair mechanisms take place between each fraction and results, particularly for the dose-effect relationship. could possibly be different if the total dose was given in one fraction. Furthermore. our results have to be confirmed by a study including more children.
